Muscle fatigue is a prominent symptom in patients with chronic heart failure (CHF). To determine whether it results from an intrinsic abnormality of vasodilating capacity of the vasculature in exercising muscle, we studied local forearm blood flow (FBF) (Circulation 1990;82:465-472) In patients with chronic heart failure (CHF), exercise capacity is usually limited by symptoms of dyspnea or fatigue. If the exercise is gradual rather than abrupt in its onset and severity, fatigue is more likely to result.' The specific cause of fatigue remains unclear, but decreases in nutritive blood flow,2,3 changes in muscle metabolism,45 and histological muscle fiber atrophy6 have been implicated.
measured with a hand dynamometer (Jamar, Alimed, Boston, Mass.). Arterial pressure was measured in the opposite arm through an intra-arterial line in the CHF patients and with a semiautomated indirect recorder (Dinamap 845XT, Critikon, Tampa, Fla.) in the normal subjects.
All studies were performed in a quiet, temperature-controlled environment (22-24°C) after an overnight fast. Patients and normal subjects were recumbent with head and shoulders comfortably supported. After 30 minutes of rest, baseline measurements of heart rate, blood pressure, cardiac output, pulmonary capillary wedge pressure, and FBF were obtained. FBF was measured with a mercuryin-Silastic rubber strain gauge applied around the dominant forearm, which was comfortably supported above the level of the heart.13 A wrist cuff was inflated to 200 mm Hg 1 minute before recordings to exclude hand blood flow.14 A venous occlusion pressure of 40 mm Hg was used in the upper arm cuff, and FBF was measured as the slope of the change in forearm volume. The venous cuff was inflated for 5-10 seconds for each flow measurement, then released. The mean of at least six flows was obtained at each measurement time. The mean of two sets of baseline flows was used as the control flow.
After a stable hemodynamic baseline had been obtained, forearm exercise was commenced and consisted of repetitive contractions on the hand dynamometer maintained for 5 seconds and released for 15 seconds, similar to that described by Zelis et al. Figure 2A . Before milrinone therapy, FBF was reduced at rest in the CHF patients compared with the normal subjects (p<0.05); however, FBF progressively increased with exercise and was not significantly different from that in normal subjects. After milrinone therapy, FBF was significantly increased at rest, but exercise blood flow was not altered. Similar changes were seen with forearm vascular resistance ( Figure 2B ) and percent forearm oxygen extraction ( Figure 2C ), which were both increased at rest in patients with CHF. Milrinone therapy decreased forearm vascular resistance and percent oxygen extraction at rest but did not alter either variable from that seen in normal subjects at each stage of exercise. Indeed, because forearm vascular resistance was higher at rest in patients with CHF than in normal subjects, yet the same at peak exercise, the reduction in forearm vascular resistance achieved during forearm exercise by patients with CHF (41.1+4.0 units) tended to be greater than that in normal subjects (31.4±3.5 units), although it did not reach statistical significance. Forearm oxygen consumption ( Figure 2D ) was normal in CHF patients at rest and was not altered by milrinone at rest or during exercise.
Because the control group completed more physical work than the CHF group, the results are also shown in Figure 3 an intrinsic defect in the vasodilating capacity of the muscle vasculature. This conclusion is supported by the observation that milrinone, a drug known to improve exercise capacity acutely in patients with CHF, although producing vasodilation at rest, did not improve vasodilation during forearm exercise.
The protocol used in this study required exercise to 45% of maximum voluntary contraction for 5 minutes, and the end point was not chosen to be maximum symptom-limited exercise capacity. However, all patients and normal subjects complained of fatigue during the protocol, and submaximal exercise may be more relevant to a patient's performance of activities of daily living than maximal exercise. The protocol was designed to be similar to that described by Zelis et al,9 except that we adjusted the strength of contraction to allow for different muscle mass in individual patients. If the present results are considered as force developed, then the patients with CHF generated less force but had a similar vasodilation to normal subjects, further supporting the conclusion that the ability of their forearm muscle vasculature to dilate was not impaired. This type of forearm exercise increased local muscle blood flow but did not increase cardiac output in the CHF patients. This represents an approximate 10 ml/min increase in FBF per 100 ml forearm volume. If the average forearm volume is 1,000 ml, then cardiac output would have been expected to increase 100 ml/min or 0.1 1/min. This is less than the measurement error of the thermodilution technique, and therefore, we cannot confirm whether the local increase in FBF resulted from a true central increase or merely a redistribution of cardiac output.
Despite similar protocols, our conclusions differ from those of Zelis et a19 and may reflect the subset of patients they studied, all of whom had rheumatic heart disease and clinical evidence of right ventricular decompensation with fluid retention. Diuresis alone in these circumstances improves vasodilator reserve capacity. 20 We did find a correlation between peak exercise blood flow and right ventricular dysfunction, as reflected by central venous pressure and right ventricular ejection fraction. This is of interest because right atrial pressure is known to negatively correlate with survival,2' and right ventricular rather than left ventricular ejection fraction correlates with upright exercise capacity in CHF. 22 Although increased central venous pressure could be associated with increased tissue sodium and water retention and a decrease in vasodilator capacity, in an experimental animal model of heart failure induced by rapid atrial pacing, modest increases in mean right atrial pressure with evidence of some fluid retention and increased muscle water content were not associated with a decrease in peripheral arterial vasodilation. 23 The degree of fluid retention was variable among the animals, and the investigators did not report a correlation between degree of fluid retention or central venous pressure and vasodilator capacity. Thus, it remains possible that the decrease in exercise blood flow seen by Zelis et a19 reflected local tissue edema secondary to the very high venous pressures present in their patients. 24, 25 Severe heart failure is also associated with neurohormonal activation,26,27 and plasma norepinephrine has been shown to correlate positively with right atrial pressure. 28 This neurohormonal activation could be a further independent influence on vasodilator capacity, although we found no association with plasma norepinephrine levels or plasma renin activity in our patients. Another consideration is that venous plethysmography assumes the veins are empty at rest. With high right atrial pressures, this may not be so, and thus, further small increments in forearm volume during intermittent venous occlusion may be operating on a flattened portion of the venous pressurevolume curve,29 thus underestimating forearm blood flow. However, significant flattening of the curve does not occur until pressures higher than 20 mm Hg, and this elevation of right atrial pressure was present in only one of our patients.
Our results support the observations of Wilson et al,10 who studied a group of nonedematous patients with less severe clinical heart failure (NYHA classes II and III) than our population, but they used a different protocol of forearm exercise. Blood flow responses in the forearm30 and biochemical alterations within the muscle31 can be dependent on the exercise protocol used. However, Wilson et al10 also found increases in blood flow to be similar between normal subjects and patients, suggesting that the reduced vasodilation seen by Zelis et a19 is more likely to be due to the edematous condition of the patients they studied rather than to differences in exercise protocol. In addition, our observations on the effects of milrinone further support the conclusion that improvements in exercise capacity of patients with compensated severe heart failure may not be mediated through alterations in the intrinsic vasodilator capacity of muscle blood vessels. Our results differ from those of LeJemtel et al,3 who compared one-leg with two-leg maximal bicycle exercise and concluded that the ability of the muscle vasculature to vasodilate is impaired in patients with CHF. However, oxygen uptake was significantly increased in their model, and thus, changes in cardiac output could have influenced their measurements of blood flow. Sullivan et a132 also studied leg blood flow during maximal upright bicycle exercise and found evidence of reduced perfusion at rest and during exercise. Because nonleg blood flow and arterial pressure were preferentially maintained during exercise at the expense of leg hypoperfusion, they concluded that a reflex-mediated peripheral vasoconstriction may occur in the exercising limb in the setting of an inadequate cardiac output response. Our findings complement the results of this study, because we studied a small muscle mass, without a change in cardiac output, and found no intrinsic abnormality in vasodilator capacity with exercise.
Improved functional capacity after vasodilator therapy in CHF could occur through other mechanisms such as increased cardiac output. During whole-body upright exercise, this could maintain muscle perfusion and perhaps performance. Thus, our results are not inconsistent with previous observations during upright exercise that blood flow to exercising skeletal muscle is reduced in CHF2 and improved by long-term administration of drugs such as captopril that increase maximum oxygen uptake. 33 Muscle fatigue and decreased performance may also involve alterations in skeletal muscle metabolism with increased phosphocreatine depletion and low pH.455Two studies in patients with heart failure have suggested that these changes do not appear to be secondary to impaired blood flow or muscle atrophy.34'35 Also, of interest, in a rat model of myocardial infarction and acute heart failure, milrinone preferentially increased blood flow to oxidative rather than glycolytic working muscle during maximal treadmill exercise.36 Hence, although total FBF was not increased in our patients, milrinone may improve the distribution between oxidative and glycolytic muscle fibers. If oxidative muscle fibers were to have better resistance to fatigue compared with glycolytic fibers, then this would be clinically helpful.
In summary, we found no impairment in the ability of the local vasculature to dilate during submaximal, intermittent forearm static exercise in patients with compensated severe CHF despite the presence of mild-to-moderate peripheral edema in some patients. Milrinone did not further increase exercise forearm blood flow. We conclude that impairment of functional exercise capacity in patients with CHF is unlikely to be due primarily to an intrinsic vasodilator abnormality of muscle blood vessels.
